Dr. Subhas Pandit

Dr. Subhas Pandit is a Clinical Oncologist at Kathmandu Cancer Center with over 16 years of oncology practice. He trained in radiation oncology at AIIMS, New Delhi — India's premier medical institution — and completed a fellowship in Head and Neck IMRT under Prof. Vincent Gregoire at UCL Belgium. He was the first oncologist to introduce IMRT and VMAT in Nepal, publishing the country's first IMRT outcomes data in Annals of Oncology. His practice spans the full spectrum of cancer care: chemotherapy, immunotherapy, targeted therapy, and precision radiotherapy.

As a Clinical Oncologist, Dr. Pandit does not choose between chemotherapy and radiation — he designs the complete treatment, integrating both from day one through the same physician. This is critical for cancers that require both modalities, such as head and neck, cervical, lung, rectal, and oesophageal cancers. Every patient is discussed at the KCC Multidisciplinary Tumour Board, ensuring that no single modality is planned in isolation.

Dr. Pandit serves as Academic Director at KCC, leading a research-focused programme that has set national standards. With 238+ Google Scholar citations, publications in Annals of Oncology, PLOS ONE, and Journal of Contemporary Brachytherapy, and invited speaking engagements across three continents, he is one of Nepal's most cited oncologists. He has authored five international book chapters and pioneered several advanced radiotherapy techniques in Nepal.

Dr. Pandit follows NCCN and WHO guidelines, integrating chemotherapy, immunotherapy, targeted therapy, and precision radiotherapy into a single coordinated plan. His training at AIIMS and UCL Belgium ensures that international standards are applied locally.

All cases are reviewed at the weekly Multidisciplinary Tumour Board, where radiation oncologists, medical oncologists, and surgeons collaborate to design the most effective treatment pathway.